Cargando…

Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9

Disabled‐1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen b...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Rang‐Juan, Li, Kai, Xing, Wan‐Ying, Du, Shuang, Li, Qiang, Zhu, Xiao‐Juan, Cui, Shu‐Sen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349202/
https://www.ncbi.nlm.nih.gov/pubmed/30484953
http://dx.doi.org/10.1111/jcmm.14047
_version_ 1783390237052895232
author Cao, Rang‐Juan
Li, Kai
Xing, Wan‐Ying
Du, Shuang
Li, Qiang
Zhu, Xiao‐Juan
Cui, Shu‐Sen
author_facet Cao, Rang‐Juan
Li, Kai
Xing, Wan‐Ying
Du, Shuang
Li, Qiang
Zhu, Xiao‐Juan
Cui, Shu‐Sen
author_sort Cao, Rang‐Juan
collection PubMed
description Disabled‐1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen breast cancer and their adjacent tissues. Our results showed that Dab1 was reduced in breast cancer, and its compromised expression correlated with triple negative breast cancer phenotype, poor differentiation, as well as lymph node metastasis. Functional analysis in breast cancer cell lines demonstrated that Dab1 promoted cell apoptosis, which, at least partially, depended on its regulation of NF‐κB/Bcl‐2/caspase‐9 pathway. Our study strongly suggests that Dab1 may be a potential tumour suppressor gene in breast cancer.
format Online
Article
Text
id pubmed-6349202
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63492022019-02-01 Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9 Cao, Rang‐Juan Li, Kai Xing, Wan‐Ying Du, Shuang Li, Qiang Zhu, Xiao‐Juan Cui, Shu‐Sen J Cell Mol Med Short Communications Disabled‐1 (Dab1) is best known as an adaptor protein regulating neuron migration and lamination during development. However, the exact function of Dab1 in breast cancer is unknown. In this study, we examined the expression of Dab1 in 38 breast cancer paraffin sections, as well as 60 paired frozen breast cancer and their adjacent tissues. Our results showed that Dab1 was reduced in breast cancer, and its compromised expression correlated with triple negative breast cancer phenotype, poor differentiation, as well as lymph node metastasis. Functional analysis in breast cancer cell lines demonstrated that Dab1 promoted cell apoptosis, which, at least partially, depended on its regulation of NF‐κB/Bcl‐2/caspase‐9 pathway. Our study strongly suggests that Dab1 may be a potential tumour suppressor gene in breast cancer. John Wiley and Sons Inc. 2018-11-28 2019-02 /pmc/articles/PMC6349202/ /pubmed/30484953 http://dx.doi.org/10.1111/jcmm.14047 Text en © 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Cao, Rang‐Juan
Li, Kai
Xing, Wan‐Ying
Du, Shuang
Li, Qiang
Zhu, Xiao‐Juan
Cui, Shu‐Sen
Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9
title Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9
title_full Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9
title_fullStr Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9
title_full_unstemmed Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9
title_short Disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through NF‐κB/Bcl‐2/caspase‐9
title_sort disabled‐1 is down‐regulated in clinical breast cancer and regulates cell apoptosis through nf‐κb/bcl‐2/caspase‐9
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349202/
https://www.ncbi.nlm.nih.gov/pubmed/30484953
http://dx.doi.org/10.1111/jcmm.14047
work_keys_str_mv AT caorangjuan disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9
AT likai disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9
AT xingwanying disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9
AT dushuang disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9
AT liqiang disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9
AT zhuxiaojuan disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9
AT cuishusen disabled1isdownregulatedinclinicalbreastcancerandregulatescellapoptosisthroughnfkbbcl2caspase9